228 institutions reported holding $2.53B of IMMUNOME (IMNM) in SEC 13F filings for 2026-06-30. Largest institutional holders: T. Rowe Price Investment Management, Inc. ($417.0M), FMR LLC ($360.0M), BlackRock, Inc. ($186.6M), VANGUARD GROUP INC ($144.0M), STATE STREET CORP ($116.4M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30